Frank Thomas, Netzel Michael, Strass Gabriele, Bitsch Roland, Bitsch Irmgard
IMFORM GmbH International Clinical Research, Birkenweg 14, D-64295 Darmstadt, Germany.
Can J Physiol Pharmacol. 2003 May;81(5):423-35. doi: 10.1139/y03-038.
Pharmacokinetic parameters and the bioavailability of several dietary anthocyanins following consumption of red wine and red grape juice were compared in nine healthy volunteers. They were given a single oral dose of either 400 mL of red wine (279.6 mg total anthocyanins) or 400 mL of red grape juice (283.5 mg total anthocyanins). Within 7 h, the urinary excretion of total anthocyanins was 0.23 and 0.18% of the administered dose following red grape juice and red wine ingestion, respectively. Pharmacokinetic parameters derived from plasma and urine concentrations exhibited higher variability after ingestion of red grape juice. Compared to red grape juice anthocyanins, the relative bioavailability of red wine anthocyanins was calculated to be 65.7, 61.3, 61.9, 291.5, 57.1, and 76.3% for the glucosides of cyanidin, delphinidin, malvidin, peonidin, petunidin, and its sum (referred to as total anthocyanins), respectively. Bioequivalence was established for none of the anthocyanins. On a low level, urinary excretion of anthocyanins was fast, and the excretion rates seem to exhibit monoexponential characteristics over time after ingestion of both red grape juice and red wine. Due to low bioavailability, any significant contribution of anthocyanins to health protecting properties of red wine or red grape juice seems questionable, but the clinical relevance of these findings awaits further investigation.
在9名健康志愿者中比较了饮用红酒和红葡萄汁后几种膳食花色苷的药代动力学参数和生物利用度。他们单次口服400毫升红酒(花色苷总量279.6毫克)或400毫升红葡萄汁(花色苷总量283.5毫克)。在7小时内,摄入红葡萄汁和红酒后,花色苷总量的尿排泄量分别为给药剂量的0.23%和0.18%。从血浆和尿液浓度得出的药代动力学参数在摄入红葡萄汁后变异性更高。与红葡萄汁花色苷相比,红酒花色苷中矢车菊素、飞燕草素、锦葵色素、芍药色素、矮牵牛色素及其总和(称为总花色苷)的糖苷的相对生物利用度分别计算为65.7%、61.3%、61.9%、291.5%、57.1%和76.3%。没有一种花色苷建立了生物等效性。在低水平下,花色苷的尿排泄很快,摄入红葡萄汁和红酒后,排泄率似乎随时间呈单指数特征。由于生物利用度低,花色苷对红酒或红葡萄汁健康保护特性的任何显著贡献似乎都值得怀疑,但这些发现的临床相关性有待进一步研究。